Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Ronald M. Rerko"'
Autor:
Earl Lawrence, Dawn M. Dawson, Monica M. Bertagnolli, Ronald M. Rerko, Robert A. Newman, Danielle Liu, Xiaohua Zhou, James Lutterbaugh, Stephen P. Fink, Seung-Jae Myung, Sanford D. Markowitz, Peiying Yang, Min Yan, Hsin Hsiung Tai, Joseph Willis, Jill S. Barnholtz-Sloan
Publikováno v:
Proceedings of the National Academy of Sciences. 106:9409-9413
Pharmacologic inhibitors of the prostaglandin-synthesizing COX-2 oncogene prevent the development of premalignant human colon adenomas. However, resistance to treatment is common. In this study, we show that the adenoma prevention activity of the COX
Autor:
Keith T. Wilson, Ronald M. Rerko, Min Tong, Guangbin Luo, James K V Willson, Shilong Lu, Sanford D. Markowitz, Dawn M. Dawson, Min Yan, Hsin Hsiung Tai, James Lutterbaugh, Joseph Willis, Jack O. Hensold, Earl Lawrence, Petra Platzer
Publikováno v:
Proceedings of the National Academy of Sciences. 101:17468-17473
Marked increased expression of cyclooxygenase 2 (COX-2), a prostaglandin-synthesizing enzyme that is pharmacologically inhibited by nonsteroid anti-inflammatory-type drugs, is a major early oncogenic event in the genesis of human colon neoplasia. We
Autor:
Sanford D. Markowitz, Theresa P. Pretlow, Lois Myeroff, Dominic J. Smiraglia, Ronald M. Rerko, Graham Casey, James Lutterbaugh, Michael F. Romero, Christoph Plass, Hui Li, James K V Willson, Jean Pierre J. Issa, Joseph Willis, Lakshmi Kasturi
Publikováno v:
Proceedings of the National Academy of Sciences. 100:8412-8417
We identify a gene, SLC5A8 , and show it is a candidate tumor suppressor gene whose silencing by aberrant methylation is a common and early event in human colon neoplasia. Aberrant DNA methylation has been implicated as a component of an epigenetic m
Publikováno v:
Infection and Immunity. 66:4537-4540
Lymph node cells of BALB/c mice with progressive leishmaniasis produced sixfold more interleukin-2 (IL-2) in culture than those of healing C57BL/6 mice. IL-2 synthesis also increased in C57BL/6 mice made susceptible by IL-12 or gamma interferon defic
Publikováno v:
Research in Immunology. 146:575-582
Summary Distinct phenotypic outcomes following infection of mice with Leishmania major are closely linked to the emergence of functionally dissimilar Th1 or Th2 CD4+ T-cell responses early in the course of disease. This model of T-cell-dependent micr
Publikováno v:
Photochemistry and Photobiology. 55:75-80
— Photosensitization mediated by Photofrin II (PFII) was found to be mutagenic at the heterozygous thymidine kinase (tk) locus in mouse L5178Y lymphoma strains LY-S1 and LY-R16 but not in strain LY-R83 which is hemizygous at the tk locus. After tre
Autor:
Theresa P. Pretlow, Petra Platzer, Min Yan, Earl Lawrence, Robert A. Newman, Alysia Kern Lovgren, Andrew J. Dannenberg, Sanford D. Markowitz, Joseph Willis, Guangbin Luo, Seung-Jae Myung, Dawn M. Dawson, Kishore Guda, Ronald M. Rerko, Angela Dotson
15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is a prostaglandin-degrading enzyme that is highly expressed in normal colon mucosa but is ubiquitously lost in human colon cancers. Herein, we demonstrate that 15-PGDH is active in vivo as a highly pot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95f61ded683d6b13bfdc2706232d9965
https://europepmc.org/articles/PMC1567703/
https://europepmc.org/articles/PMC1567703/
Autor:
Elaine B, Brunschwig, Keith, Wilson, David, Mack, Dawn, Dawson, Earl, Lawrence, James K V, Willson, ShiLong, Lu, Arman, Nosrati, Ronald M, Rerko, Sandra, Swinler, Lydia, Beard, James D, Lutterbaugh, Joseph, Willis, Petra, Platzer, Sanford, Markowitz
Publikováno v:
Cancer research. 63(7)
To identify potential effectors of transforming growth factor (TGF)-beta-mediated suppression of colon cancer, we used GeneChip expression microarrays to identify TGF-beta-induced genes in VACO 330, a nontransformed TGF-beta-sensitive cell line deriv
Autor:
Frederick P. Heinzel, Ronald M. Rerko
Publikováno v:
The Journal of Experimental Medicine
Progressive infection with Leishmania major in susceptible BALB/c mice is mediated by interleukin (IL)-4–producing T helper cell type 2 (Th2) CD4+ T cells that, once established, become resistant to Th1-deviating therapies with recombinant (r)IL-12
Publikováno v:
Cellular immunology. 184(2)
Interleukin-12 promotes Th1 lymphocyte responses necessary for the cure of murine Leishmania major infection. We found that IL-12 p40 mRNA expression peaked at 4 weeks of infection in resistant C57BL/6 mice at levels threefold greater than in BALB/c